Logo image of LBNK.CA

LITHIUMBANK RESOURCES CORP (LBNK.CA) Stock Fundamental Analysis

TSX-V:LBNK - TSX Venture Exchange - CA53681T1012 - Common Stock - Currency: CAD

0.26  -0.02 (-8.77%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to LBNK. LBNK was compared to 818 industry peers in the Metals & Mining industry. While LBNK seems to be doing ok healthwise, there are quite some concerns on its profitability. LBNK does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

In the past year LBNK has reported negative net income.
LBNK had a negative operating cash flow in the past year.
LBNK.CA Yearly Net Income VS EBIT VS OCF VS FCFLBNK.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 -2M -4M -6M

1.2 Ratios

Looking at the Return On Assets, with a value of -7.64%, LBNK is in the better half of the industry, outperforming 62.03% of the companies in the same industry.
LBNK's Return On Equity of -8.77% is fine compared to the rest of the industry. LBNK outperforms 64.46% of its industry peers.
Industry RankSector Rank
ROA -7.64%
ROE -8.77%
ROIC N/A
ROA(3y)-55.17%
ROA(5y)N/A
ROE(3y)-72.17%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
LBNK.CA Yearly ROA, ROE, ROICLBNK.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 -20 -40 -60 -80 -100

1.3 Margins

LBNK does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
LBNK.CA Yearly Profit, Operating, Gross MarginsLBNK.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023

6

2. Health

2.1 Basic Checks

The number of shares outstanding for LBNK has been increased compared to 1 year ago.
LBNK has a worse debt/assets ratio than last year.
LBNK.CA Yearly Shares OutstandingLBNK.CA Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 10M 20M 30M 40M
LBNK.CA Yearly Total Debt VS Total AssetsLBNK.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2M 4M 6M 8M 10M

2.2 Solvency

Based on the Altman-Z score of 1.15, we must say that LBNK is in the distress zone and has some risk of bankruptcy.
LBNK has a Altman-Z score (1.15) which is comparable to the rest of the industry.
LBNK has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 1.15
ROIC/WACCN/A
WACCN/A
LBNK.CA Yearly LT Debt VS Equity VS FCFLBNK.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 0 5M -5M

2.3 Liquidity

A Current Ratio of 4.37 indicates that LBNK has no problem at all paying its short term obligations.
The Current ratio of LBNK (4.37) is better than 71.76% of its industry peers.
LBNK has a Quick Ratio of 4.37. This indicates that LBNK is financially healthy and has no problem in meeting its short term obligations.
LBNK has a better Quick ratio (4.37) than 72.70% of its industry peers.
Industry RankSector Rank
Current Ratio 4.37
Quick Ratio 4.37
LBNK.CA Yearly Current Assets VS Current LiabilitesLBNK.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2M 4M 6M 8M 10M

0

3. Growth

3.1 Past

LBNK shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 74.90%, which is quite impressive.
EPS 1Y (TTM)74.9%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0.36%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y28.71%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
LBNK.CA Yearly Revenue VS EstimatesLBNK.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024
LBNK.CA Yearly EPS VS EstimatesLBNK.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 -0.05 -0.1 -0.15

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for LBNK. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for LBNK. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
LBNK.CA Price Earnings VS Forward Price EarningsLBNK.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
LBNK.CA Per share dataLBNK.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.1 -0.1 0.2 -0.2 0.3

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

LBNK does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

LITHIUMBANK RESOURCES CORP

TSX-V:LBNK (2/21/2025, 7:00:00 PM)

0.26

-0.02 (-8.77%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)02-03 2025-02-03
Earnings (Next)N/A N/A
Inst Owners0.3%
Inst Owner ChangeN/A
Ins Owners12.67%
Ins Owner ChangeN/A
Market Cap12.97M
Analysts80
Price Target3.57 (1273.08%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 0.84
P/tB 1.14
EV/EBITDA N/A
EPS(TTM)-0.17
EYN/A
EPS(NY)-0.12
Fwd EYN/A
FCF(TTM)-0.26
FCFYN/A
OCF(TTM)-0.19
OCFYN/A
SpS0
BVpS0.31
TBVpS0.23
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -7.64%
ROE -8.77%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-55.17%
ROA(5y)N/A
ROE(3y)-72.17%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 4.37
Quick Ratio 4.37
Altman-Z 1.15
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)74.9%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0.36%
EPS Next Y28.71%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-48.45%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year32.04%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y13.72%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-35.86%
OCF growth 3YN/A
OCF growth 5YN/A